Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 7/20 | 0.46 |
| ▸ | MAPT | P10636 | 6/20 | 0.46 |
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | NOX1 | Q9Y5S8 | 4/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.46 |
| ▸ | BCHE | P06276 | 2/20 | 0.46 |
| ▸ | ACHE | P22303 | 2/20 | 0.46 |
| ▸ | SNCA | P37840 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | CNR1 | P21554 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9635081 | 0.76 | CA12 (0.52) | GAAMAPTALOX15POLBTDP1 | |
| SCHEMBL4510651 | 0.75 | GAA (0.52) | GAAMAPTMEN1KMT2ANOX1 | |
| SCHEMBL15631689 | 0.73 | NOX1 (0.39) | GAAMAPTMEN1KMT2ANOX1 | |
| SCHEMBL7275482 | 0.73 | MEN1 (0.46) | GAAMAPTMEN1KMT2ATDP1 | |
| SCHEMBL9834304 | 0.72 | GAA (0.40) | GAAMAPTMEN1KMT2ANOX1 | |
| SCHEMBL7427944 | 0.72 | ALDH1A1 (0.48) | GAAMAPTMEN1KMT2ANOX1 | |
| SCHEMBL8853727 | 0.72 | GAA (0.54) | GAAMAPTMEN1KMT2ANOX1 | |
| SCHEMBL5739509 | 0.71 | CYP2A6 (0.35) | PTGS2TDP1ALDH1A1RAB9AKDM4E | |
| SCHEMBL9628939 | 0.71 | NPC1 (0.53) | GAAMAPTMEN1KMT2ANOX1 | |
| SCHEMBL9850768 | 0.71 | ALDH1A1 (0.47) | GAAMAPTMEN1KMT2AALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111630167-B | Antisense oligonucleotides for modulating T cell function | 新加坡科技研究局 | 2024-08-09 | — | — | CN | disclosed |
| CN-118265791-A | Spherical nucleic acids for cGAS-STING and STAT3 pathway modulation for immunotherapeutic treatment of cancer | 西北大学 | 2024-06-28 | — | — | CN | disclosed |
| CN-117835967-A | Compositions and methods for targeted delivery to cells | 瑞科德治疗公司 | 2024-04-05 | — | — | CN | disclosed |
| CN-117751190-A | Compositions and methods for modulating SOS gene expression | 美国微哲默理有限责任公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117750948-A | Compositions and methods for targeted systemic delivery to cells | 瑞科德治疗公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-117683769-A | Nucleic acid oligomer and use thereof | 瑞普鲁卡私人有限公司 | 2024-03-12 | — | — | CN | disclosed |
| CN-117597112-A | Extracellular vesicles loaded with biomolecules | 鉴识生物系统有限公司 | 2024-02-23 | — | — | CN | disclosed |
| CN-117157104-A | Targeting multiple T cell types using spherical nucleic acid vaccine architecture | 西北大学 | 2023-12-01 | — | — | CN | disclosed |
| CN-116940679-A | Oligomeric compounds for dystrophin rescue in DMD patients by skipping of exon-51 | SQY治疗公司 | 2023-10-24 | — | — | CN | disclosed |
| CN-116802193-A | Engineered coronavirus spike (S) proteins and methods of use thereof | 得克萨斯州大学系统董事会 | 2023-09-22 | — | — | CN | disclosed |
| CN-109796423-B | Method for synthesizing 1, 3-thiazine-4-ketone under metal-free catalysis condition | 温州大学 | 2022-11-11 | — | — | CN | disclosed |
| US-20220340890-A1 | RNA-GUIDED NUCLEASES AND DNA BINDING PROTEINS | INARI AGRICULTURE TECHNOLOGY, INC. | 2022-10-27 | — | — | US | disclosed |
| CN-114929336-A | Compounds and methods for modulating gene splicing | 阿尔奈科学有限责任公司 | 2022-08-19 | — | — | CN | disclosed |
| CN-114207129-A | Agents and methods for replication, transcription and translation in semi-synthetic organisms | 斯克利普斯研究所 | 2022-03-18 | — | — | CN | disclosed |
| CN-114058617-A | Conjugated antisense compounds and uses thereof | IONIS制药公司 | 2022-02-18 | — | — | CN | disclosed |
| US-20190119726-A1 | ERROR CORRECTION IN AMPLIFICATION OF SAMPLES | CELLULAR RESEARCH, INC. | 2019-04-25 | — | — | US | disclosed |
| WO-2012083363-A1 | A METHOD OF TREATMENT | MURDOCH CHILDRENS RESEARCH INSTITUTE (AU) | 2012-06-28 | — | — | WO | disclosed |
| EP-0529452-B1 | 1,7-Condensed 3-(piperazinoalkyl)indol derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them | SOLVAY PHARM GMBH (DE) | 1998-11-11 | — | — | EP | disclosed |
| US-5324725-A | Antiinflammatory agent, antiallergen | KALI-CHEMIE PHARMA GMBH (DE) | 1994-06-28 | — | — | US | disclosed |
| EP-0529452-A2 | 1,7-Condensed 2-(piperazinoalkyl)indol derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them | Kali-Chemie Pharma GmbH (DE) | 1993-03-03 | — | — | EP | disclosed |